Rock Creek Pharma (RCPI) Completes Anatabine Citrate Phase 1 Trial in U.K.

Go back to Rock Creek Pharma (RCPI) Completes Anatabine Citrate Phase 1 Trial in U.K.
(AMEX: RCPI) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $1.26 
Open $0.01    52 Week Low $0.00 
Day High $0.01    P/E N/A 
Day Low $0.00    EPS $0.00 
Volume 22,156,939